Biotech stocks rallied in June, with the ALPS Medical Breakthroughs ETF (SBIO) posting a +18.7% return—its best month since December 2023. The strength propelled SBIO to among the top performers across the ALPS lineup, signaling improving risk appetite toward biotech equities.
Biotech stocks rallied in June, with the ALPS Medical Breakthroughs ETF (SBIO) posting a +18.7% return—its best month since December 2023. The strength propelled SBIO to among the top performers across the ALPS lineup, signaling improving risk appetite toward biotech equities.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
moderately positive
Sentiment Score
0.45
